Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns

Newborns from mothers with immune thrombocytopenic purpura (ITP) have a risk of thrombocytopenia due to passage of maternal antiplatelet antibodies into fetal/neonatal circulation. We looked for predictors of neonatal thrombocytopenia (nTP) in pregnant women with ITP. One hundred pregnant women with...

Full description

Bibliographic Details
Main Authors: Svetlana G. Khaspekova, Olga N. Shustova, Nina V. Golubeva, Yaroslav A. Naimushin, Lyubov E. Larina, Alexey V. Mazurov
Format: Article
Language:English
Published: Taylor & Francis Group 2019-11-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2018.1557615
_version_ 1797684192198262784
author Svetlana G. Khaspekova
Olga N. Shustova
Nina V. Golubeva
Yaroslav A. Naimushin
Lyubov E. Larina
Alexey V. Mazurov
author_facet Svetlana G. Khaspekova
Olga N. Shustova
Nina V. Golubeva
Yaroslav A. Naimushin
Lyubov E. Larina
Alexey V. Mazurov
author_sort Svetlana G. Khaspekova
collection DOAJ
description Newborns from mothers with immune thrombocytopenic purpura (ITP) have a risk of thrombocytopenia due to passage of maternal antiplatelet antibodies into fetal/neonatal circulation. We looked for predictors of neonatal thrombocytopenia (nTP) in pregnant women with ITP. One hundred pregnant women with platelet count <100 × 109/l, no non-immune causes of thrombocytopenia and increased platelet associated IgG (PA-IgG) were included in the study. Thirty seven and 63 of them gave birth to babies with and without nTP, respectively (nTP+ and nTP− groups). Platelet count, mean platelet volume, PA-IgG, antiplatelet circulating antibodies (cAB), time of ITP onset (before or during pregnancy), and frequency of corticosteroid treatment were compared in these groups. There were no differences in all test parameters between nTP+ and nTP− groups except cAB. These antibodies were detected in 33 out of 37 in nTP+ group and in 2 out of 63 mothers in nTP− group (p < 0.001). The sensitivity of this test was 89% and its specificity was 97%. A strong reverse correlation (r = −0.749, p < 0.001) was established between maternal cAB titer and neonatal platelet count. Antibodies against glycoproteins IIb–IIIa and/or Ib were identified in antigen specific MAIPA (Monoclonal Antibody Immobilization of Platelet Antigen) assay only in 10 out of 19 (53%) test sera with cAB. Antiplatelet cAB in pregnant women with ITP could serve as reliable predictors of nTP in their babies.
first_indexed 2024-03-12T00:26:55Z
format Article
id doaj.art-37e249024a604a1c8519f0bb5b208fcd
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2024-03-12T00:26:55Z
publishDate 2019-11-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-37e249024a604a1c8519f0bb5b208fcd2023-09-15T10:32:01ZengTaylor & Francis GroupPlatelets0953-71041369-16352019-11-013081008101210.1080/09537104.2018.15576151557615Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newbornsSvetlana G. Khaspekova0Olga N. Shustova1Nina V. Golubeva2Yaroslav A. Naimushin3Lyubov E. Larina4Alexey V. Mazurov5Ministry of HealthMinistry of HealthMinistry of HealthMinistry of HealthPirogov Russian National Research Medical University, Ministry of HealthMinistry of HealthNewborns from mothers with immune thrombocytopenic purpura (ITP) have a risk of thrombocytopenia due to passage of maternal antiplatelet antibodies into fetal/neonatal circulation. We looked for predictors of neonatal thrombocytopenia (nTP) in pregnant women with ITP. One hundred pregnant women with platelet count <100 × 109/l, no non-immune causes of thrombocytopenia and increased platelet associated IgG (PA-IgG) were included in the study. Thirty seven and 63 of them gave birth to babies with and without nTP, respectively (nTP+ and nTP− groups). Platelet count, mean platelet volume, PA-IgG, antiplatelet circulating antibodies (cAB), time of ITP onset (before or during pregnancy), and frequency of corticosteroid treatment were compared in these groups. There were no differences in all test parameters between nTP+ and nTP− groups except cAB. These antibodies were detected in 33 out of 37 in nTP+ group and in 2 out of 63 mothers in nTP− group (p < 0.001). The sensitivity of this test was 89% and its specificity was 97%. A strong reverse correlation (r = −0.749, p < 0.001) was established between maternal cAB titer and neonatal platelet count. Antibodies against glycoproteins IIb–IIIa and/or Ib were identified in antigen specific MAIPA (Monoclonal Antibody Immobilization of Platelet Antigen) assay only in 10 out of 19 (53%) test sera with cAB. Antiplatelet cAB in pregnant women with ITP could serve as reliable predictors of nTP in their babies.http://dx.doi.org/10.1080/09537104.2018.1557615antiplatelet antibodiesimmune thrombocytopenic purpuraneonatal thrombocytopeniapregnancy
spellingShingle Svetlana G. Khaspekova
Olga N. Shustova
Nina V. Golubeva
Yaroslav A. Naimushin
Lyubov E. Larina
Alexey V. Mazurov
Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns
Platelets
antiplatelet antibodies
immune thrombocytopenic purpura
neonatal thrombocytopenia
pregnancy
title Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns
title_full Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns
title_fullStr Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns
title_full_unstemmed Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns
title_short Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns
title_sort circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns
topic antiplatelet antibodies
immune thrombocytopenic purpura
neonatal thrombocytopenia
pregnancy
url http://dx.doi.org/10.1080/09537104.2018.1557615
work_keys_str_mv AT svetlanagkhaspekova circulatingantiplateletantibodiesinpregnantwomenwithimmunethrombocytopenicpurpuraaspredictorsofthrombocytopeniainthenewborns
AT olganshustova circulatingantiplateletantibodiesinpregnantwomenwithimmunethrombocytopenicpurpuraaspredictorsofthrombocytopeniainthenewborns
AT ninavgolubeva circulatingantiplateletantibodiesinpregnantwomenwithimmunethrombocytopenicpurpuraaspredictorsofthrombocytopeniainthenewborns
AT yaroslavanaimushin circulatingantiplateletantibodiesinpregnantwomenwithimmunethrombocytopenicpurpuraaspredictorsofthrombocytopeniainthenewborns
AT lyubovelarina circulatingantiplateletantibodiesinpregnantwomenwithimmunethrombocytopenicpurpuraaspredictorsofthrombocytopeniainthenewborns
AT alexeyvmazurov circulatingantiplateletantibodiesinpregnantwomenwithimmunethrombocytopenicpurpuraaspredictorsofthrombocytopeniainthenewborns